Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care
Cardiac Failure Review · 16.06.2026
DOI: 10.15420/cfr.2025.57 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiac Failure Review, online erschienen am 16.06.2026. Verfasst von Jolie Bruno und 5 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR-S 942, Cardiovascular Markers in Stress Condition (MASCOT) Paris, France. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) continues to challenge clinicians worldwide, not only because of its high morbidity and mortality but also due to the persistent difficulty in translating therapeutic advances into routine care. Despite the availability of effective treatments, data show striking gaps in the optimal use of guideline-directed medical therapy. Among the four pillars of guideline-directed medical therapy, mineralocorticoid receptor antagonists (MRAs) remain the least prescribed. This underuse is concerning considering the evidence demonstrating consistent benefits of MRAs across different HF phenotypes. In this review, we revisit the role of MRAs across the spectrum of HF. We summarise the supporting evidence, discuss their mechanisms of action and provide practical guidance on patient eligibility and initiation strategies. In addition, we address common barriers that often limit their use. By combining mechanistic insights, trial evidence and pragmatic recommendations, this review aims to facilitate broader and earlier use of MRAs, thereby helping to close a major gap in the implementation of evidence-based HF care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM UMR-S 942, Cardiovascular Markers in Stress Condition (MASCOT) Paris, France.
- Université de Paris Cité Paris, France.
- Department of Anesthesiology, Critical Care and Burn Unit, University Hospitals Saint-Louis et Lariboisière, AP-HP Paris, France.
- Department of Cardiology, Inselspital, Bern University Hospital Bern, Switzerland.
- Department of Internal Medicine, Advanced Cardiovascular Disease and Heart Failure, Pontifícia Universidade Católica do Paraná Curitiba, Brazil.
- Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Medical Faculty, Vilnius University Vilnius, Lithuania.
ORCID-Profile: Jolie Bruno, Alexandre Mebazaa, Lídia Zytynski Moura, Jelena Čelutkienė, Andrew Sindone, Giuseppe Rosano
Zitieren
APA
Bruno, J., Mebazaa, A., Moura, L. Z., Čelutkienė, J., Sindone, A., & Rosano, G. (2026). Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care. Cardiac Failure Review. https://doi.org/10.15420/cfr.2025.57
Vancouver
Bruno J, Mebazaa A, Moura LZ, Čelutkienė J, Sindone A, Rosano G. Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care. Cardiac Failure Review. 2026. doi:10.15420/cfr.2025.57
BibTeX
@article{Bruno2026,
author = {Bruno, Jolie and Mebazaa, Alexandre and Moura, Lídia Zytynski and Čelutkienė, Jelena and Sindone, Andrew and Rosano, Giuseppe},
title = {Mineralocorticoid Receptor Antagonist Use in Contemporary Heart Failure Care},
journal = {Cardiac Failure Review},
year = {2026},
doi = {10.15420/cfr.2025.57}
}
EUVIMED